149 related articles for article (PubMed ID: 19436238)
1. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
[TBL] [Abstract][Full Text] [Related]
2. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
Shah I; Parikh S
J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
[TBL] [Abstract][Full Text] [Related]
3. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
[TBL] [Abstract][Full Text] [Related]
4. An Evaluation of Alternative Markers to Guide Initiation of Anti-retroviral Therapy in HIV-Infected Children in Settings where CD4 Assays are not Available.
Huibers MH; Moons P; Maseko N; Gushu MB; Wit FW; Graham SM; van Hensbroek MB; Calis JC
J Trop Pediatr; 2016 Feb; 62(1):19-28. PubMed ID: 26491058
[TBL] [Abstract][Full Text] [Related]
5. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.
Munthali C; Taegtmeyer M; Garner PG; Lalloo DG; Squire SB; Corbett EL; Ford N; MacPherson P
J Int AIDS Soc; 2014; 17(1):18932. PubMed ID: 24929097
[TBL] [Abstract][Full Text] [Related]
7. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
Gautam H; Saini S; Bhalla P; Singh T
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
[TBL] [Abstract][Full Text] [Related]
8. Implementation of antiretroviral therapy guidelines for under-five children in Tanzania: translating recommendations into practice.
Nuwagaba-Biribonwoha H; Wang C; Kilama B; Jowhar FK; Antelman G; Panya MF; Abrams EJ;
J Int AIDS Soc; 2015; 18(1):20303. PubMed ID: 26690303
[TBL] [Abstract][Full Text] [Related]
9. Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population.
Morpeth SC; Crump JA; Shao HJ; Ramadhani HO; Kisenge PR; Moylan CA; Naggie S; Caram LB; Landman KZ; Sam NE; Itemba DK; Shao JF; Bartlett JA; Thielman NM
AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1230-6. PubMed ID: 17961109
[TBL] [Abstract][Full Text] [Related]
10. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
[TBL] [Abstract][Full Text] [Related]
11. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
[TBL] [Abstract][Full Text] [Related]
12. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
13. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
Spacek LA; Griswold M; Quinn TC; Moore RD
AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
[TBL] [Abstract][Full Text] [Related]
14. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
Gitura B; Joshi MD; Lule GN; Anzala O
East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
[TBL] [Abstract][Full Text] [Related]
15. Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.
Paintsil E; Ghebremichael M; Romano S; Andiman WA
Pediatr Infect Dis J; 2008 Jul; 27(7):629-35. PubMed ID: 18520446
[TBL] [Abstract][Full Text] [Related]
16. Profile of HIV infected children from Delhi and their response to antiretroviral treatment.
Gomber S; Kaushik JS; Chandra J; Anand R
Indian Pediatr; 2011 Sep; 48(9):703-7. PubMed ID: 22102996
[TBL] [Abstract][Full Text] [Related]
17. Pediatric HIV care and treatment services in Tanzania: implications for survival.
Somi G; Majigo M; Manyahi J; Nondi J; Agricola J; Sambu V; Todd J; Rwebembera A; Makyao N; Ramadhani A; Matee M
BMC Health Serv Res; 2017 Aug; 17(1):540. PubMed ID: 28784131
[TBL] [Abstract][Full Text] [Related]
18. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.
Carter RJ; Dugan K; El-Sadr WM; Myer L; Otieno J; Pungpapong N; Toro PL; Abrams EJ;
J Acquir Immune Defic Syndr; 2010 Nov; 55(3):404-10. PubMed ID: 20595905
[TBL] [Abstract][Full Text] [Related]
19. Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility.
Callens SF; Kitetele F; Lusiama J; Shabani N; Edidi S; Colebunders R; Behets F; Van Rie A
BMC Infect Dis; 2008 Mar; 8():31. PubMed ID: 18325119
[TBL] [Abstract][Full Text] [Related]
20. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
